Unresectable Malignant Solid Neoplasm Clinical Trials in Rochester, Minnesota

3 studies are recruiting for unresectable malignant solid neoplasm in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) …

    Stage
    Phase 2
    Ages
    Any age
    Site
    Mayo Clinic in Rochester, Rochester, Minnesota
    Locations
    482 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05564377 on ClinicalTrials.gov

  2. Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors

    This clinical trial evaluates whether adding spatially fractionated radiation therapy (SFRT) to standard palliative external beam radiation therapy (EBRT) improves disease-related symptoms in patients with solid tumors that cannot be removed by surgery (unresectable). SFRT, originally termed GRID t…

    Stage
    Not phased
    Ages
    15 and older
    Site
    Mayo Clinic in Rochester, Rochester, Minnesota
    Locations
    2 in total
    Run by
    Mayo Clinic

    See if you can join NCT07856394 on ClinicalTrials.gov

  3. Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

    This phase I trial identifies the side effects and best dose of DS-8201a and olaparib in treating patients with HER2-expressing cancers that have spread to other places in the body or cannot be removed by surgery or ovarian cancer that remains despite treatment with a platinum treatment (platinum r…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Mayo Clinic in Rochester, Rochester, Minnesota
    Locations
    13 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT04585958 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.